Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J PERLMAN

Showing results (261-270 of 319) with videos related to

Pageof 32
Sort By:
Journal of the American College of Cardiology|June 12, 2010
A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndromeRon Waksman, Rebecca Torguson, Kenneth M Kent, et al.
Cancer|July 7, 2005
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group studyNeyssa Marina, Kay W Chang, Marcio Malogolowkin, et al.
Cell Reports. Medicine|May 26, 2022
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 studySamantha Gadd, Vicki Huff, Andrew D Skol, et al.
Cancer|June 16, 2018
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testingMariana M Cajaiba, Lisa M Dyer, James I Geller, et al.
Genes, Chromosomes & Cancer|September 2, 2011
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumorRichard D Williams, Reem Al-Saadi, Rachael Natrajan, et al.
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer|May 28, 2016
Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology GroupPeter F Ehrlich, Thomas E Hamilton, Kenneth Gow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
Pageof 32

Showing results (261-270 of 319) with videos related to

Sort By:
Pageof 32
Journal of the American College of Cardiology|June 12, 2010
A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndromeRon Waksman, Rebecca Torguson, Kenneth M Kent, et al.
Cancer|July 7, 2005
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group studyNeyssa Marina, Kay W Chang, Marcio Malogolowkin, et al.
Cell Reports. Medicine|May 26, 2022
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 studySamantha Gadd, Vicki Huff, Andrew D Skol, et al.
Cancer|June 16, 2018
The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testingMariana M Cajaiba, Lisa M Dyer, James I Geller, et al.
Genes, Chromosomes & Cancer|September 2, 2011
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumorRichard D Williams, Reem Al-Saadi, Rachael Natrajan, et al.
Cancer|September 14, 2020
A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 studyJames I Geller, Nicholas G Cost, Yueh-Yun Chi, et al.
Pediatric Blood & Cancer|May 28, 2016
Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology GroupPeter F Ehrlich, Thomas E Hamilton, Kenneth Gow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2005
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology GroupMark L Bernstein, Meenakshi Devidas, Dominique Lafreniere, et al.
Pediatric Blood & Cancer|December 21, 2012
Children's Oncology Group's 2013 blueprint for research: renal tumorsJeffrey S Dome, Conrad V Fernandez, Elizabeth A Mullen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 studyNajat C Daw, Yueh-Yun Chi, Yeonil Kim, et al.
Pageof 32